Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
shape decrease » shape increases (Expand Search), small decrease (Expand Search), step decrease (Expand Search)
Showing 1,021 - 1,040 results of 21,342 for search '(( significant decrease decrease ) OR ( significant ((shape decrease) OR (treatment decreased)) ))', query time: 0.56s Refine Results
  1. 1021
    Adult <i>Shroom3</i><sup><i>+</i></sup><sup><i>/Gt</i></sup> hearts show decreased cardiomyocyte cross-sectional area.

    Adult <i>Shroom3</i><sup><i>+</i></sup><sup><i>/Gt</i></sup> hearts show decreased cardiomyocyte cross-sectional area. by Jennifer L. Carleton (22208916)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 1022
    Socio-demographic and medical characteristics of patients with liver cancer.

    Socio-demographic and medical characteristics of patients with liver cancer. by Ayana Ablayeva (22103708)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 1023
    Data cleaning and preparation algorithm.

    Data cleaning and preparation algorithm. by Ayana Ablayeva (22103708)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 1024
    Crude and age-specific incidence rates (A), all-cause mortality rates (B), and prevalence rates (C) of liver cancer per 100,000 over 2014–2023.

    Crude and age-specific incidence rates (A), all-cause mortality rates (B), and prevalence rates (C) of liver cancer per 100,000 over 2014–2023. by Ayana Ablayeva (22103708)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 1025
    Crude and type-specific incidence rates (A), all-cause mortality rates (B), and prevalence rates (C) of liver cancer per 100,000 over 2014–2023.

    Crude and type-specific incidence rates (A), all-cause mortality rates (B), and prevalence rates (C) of liver cancer per 100,000 over 2014–2023. by Ayana Ablayeva (22103708)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 1026
    Age-adjusted annual percent changes (APC) in incidence (A), mortality (B), and prevalence (C) rates per 100,000 over 2014–2023 for both sexes and sex-specific.

    Age-adjusted annual percent changes (APC) in incidence (A), mortality (B), and prevalence (C) rates per 100,000 over 2014–2023 for both sexes and sex-specific. by Ayana Ablayeva (22103708)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 1027
    Association between socio-demographic and medical parameters and all-cause mortality rates of liver cancer between 2014 and 2023.

    Association between socio-demographic and medical parameters and all-cause mortality rates of liver cancer between 2014 and 2023. by Ayana Ablayeva (22103708)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 1028
    Crude and stage-specific incidence rate of liver cancer per 100,000 over 2014–2023.

    Crude and stage-specific incidence rate of liver cancer per 100,000 over 2014–2023. by Ayana Ablayeva (22103708)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 1029
    Crude and age-specific mortality to incidence ratios of liver cancer per 100,000 over 2014–2023.

    Crude and age-specific mortality to incidence ratios of liver cancer per 100,000 over 2014–2023. by Ayana Ablayeva (22103708)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 1030
    Crude and residence-specific incidence rates (A), all-cause mortality rates (B), and prevalence rates (C) of liver cancer per 100,000 over 2014–2023.

    Crude and residence-specific incidence rates (A), all-cause mortality rates (B), and prevalence rates (C) of liver cancer per 100,000 over 2014–2023. by Ayana Ablayeva (22103708)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 1031
    Age- and sex- specific median yearly incidence (A) and mortality (B) rate of liver cancer per 10⁶ population over 2014–2023.

    Age- and sex- specific median yearly incidence (A) and mortality (B) rate of liver cancer per 10⁶ population over 2014–2023. by Ayana Ablayeva (22103708)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 1032
    Regional and temporal burden of liver cancer in Kazakhstan (2014–2023).

    Regional and temporal burden of liver cancer in Kazakhstan (2014–2023). by Ayana Ablayeva (22103708)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 1033
    A) CaCO<sub>3</sub> content versus number of treatments; B) UCS versus calcium carbonate content; C) permeability coefficient versus calcium carbonate content.

    A) CaCO<sub>3</sub> content versus number of treatments; B) UCS versus calcium carbonate content; C) permeability coefficient versus calcium carbonate content. by Jin Zhu (164147)

    Published 2025
    Subjects: “…permeability coefficients decreased…”
    Save to List
    Saved in:
  14. 1034
    Entomopathogenic fungi-derived copper nanoparticles (CuNPs) exhibited pupicidal activity against pupae of <i>A</i>. <i>albopictus</i> at 24 and 48h post treatment.

    Entomopathogenic fungi-derived copper nanoparticles (CuNPs) exhibited pupicidal activity against pupae of <i>A</i>. <i>albopictus</i> at 24 and 48h post treatment. by Perumal Vivekanandhan (4863484)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  15. 1035
    Entomopathogenic fungi-derived copper nanoparticles (CuNPs) exhibited adulticidal activity against adult of <i>A</i>. <i>albopictus</i> at 24 and 48h post treatment.

    Entomopathogenic fungi-derived copper nanoparticles (CuNPs) exhibited adulticidal activity against adult of <i>A</i>. <i>albopictus</i> at 24 and 48h post treatment. by Perumal Vivekanandhan (4863484)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  16. 1036
    Entomopathogenic fungi-derived copper nanoparticles (CuNPs) exhibited larvicidal activity against larvae of <i>A</i>. <i>albopictu</i> at 24 and 48h post treatment.

    Entomopathogenic fungi-derived copper nanoparticles (CuNPs) exhibited larvicidal activity against larvae of <i>A</i>. <i>albopictu</i> at 24 and 48h post treatment. by Perumal Vivekanandhan (4863484)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  17. 1037
    Entomopathogenic fungi-derived copper nanoparticles (CuNPs) exhibited minimal toxicity effects against <i>E</i>. <i>eugeniae</i> at 24 and 48h post treatment.

    Entomopathogenic fungi-derived copper nanoparticles (CuNPs) exhibited minimal toxicity effects against <i>E</i>. <i>eugeniae</i> at 24 and 48h post treatment. by Perumal Vivekanandhan (4863484)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  18. 1038
    Entomopathogenic fungi-derived copper nanoparticles (CuNPs) exhibited minimal toxicity effects against <i>A</i>. <i>salina</i> at 24 and 48h post treatment.

    Entomopathogenic fungi-derived copper nanoparticles (CuNPs) exhibited minimal toxicity effects against <i>A</i>. <i>salina</i> at 24 and 48h post treatment. by Perumal Vivekanandhan (4863484)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  19. 1039
    LED modules installations on Chinese saury fishing vessels on-site.

    LED modules installations on Chinese saury fishing vessels on-site. by Fei Li (143236)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 1040
    Illuminations (a) and attenuation rates (b) of the RVL along the axis of y = 0 m at different angles.

    Illuminations (a) and attenuation rates (b) of the RVL along the axis of y = 0 m at different angles. by Fei Li (143236)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: